| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/30/2002 | US6379688 Preservative for emulsion and emulsion containing same |
| 04/30/2002 | US6379685 Acidic aqueous chlorite teat dip with improved emollient providing shelf life, sanitizing capacity and tissue protection |
| 04/30/2002 | US6379683 Lipid core encapsulated with polymer |
| 04/30/2002 | US6379682 Cosmetics, drugs |
| 04/30/2002 | US6379681 Oil-in-water emulsions for reconstituting lamellarity of the lipid structure of damaged skin |
| 04/30/2002 | US6379680 Emulsifier-free finely dispersed systems of the water-in-oil type |
| 04/30/2002 | US6379651 Administering and ingesting peroral tablets of an antibiotic/antibacterial compound with a bismuth compound, and chewing within oral cavity |
| 04/30/2002 | US6379648 Biodegradable glass compositions and methods for radiation therapy |
| 04/30/2002 | US6379379 Stent with smooth ends |
| 04/30/2002 | US6378527 Cell-culture and polymer constructs |
| 04/30/2002 | US6378526 Methods of ophthalmic administration |
| 04/30/2002 | CA2230307C Aquatic animal treatment method and composition containing cajeput oil |
| 04/30/2002 | CA2203663C Cisapride extended release oral compositions |
| 04/30/2002 | CA2177823C Poly-beta-1-->4-n-acetylglucosamine |
| 04/30/2002 | CA2131761C Crystals of pyridonecarboxylic acid derivative |
| 04/30/2002 | CA2096963C A two-phase topical composition |
| 04/30/2002 | CA2059319C Formulations for oral administration, in particular to ruminants |
| 04/27/2002 | CA2360034A1 Multicore type carotenoid beads |
| 04/27/2002 | CA2359401A1 Use of terpene alcohol ethoxylates as solubilizers in cosmetic or pharmaceutical preparations or concentrates for food preparations |
| 04/25/2002 | WO2002033045A2 Oligonucleotide - facilitated coalescence |
| 04/25/2002 | WO2002033044A2 Methods of high-throughput screening for internalizing antibodies |
| 04/25/2002 | WO2002032943A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 04/25/2002 | WO2002032906A1 Pharmaceutical compositions |
| 04/25/2002 | WO2002032874A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 04/25/2002 | WO2002032871A2 Compounds and methods for treating multidrug resistance |
| 04/25/2002 | WO2002032869A2 Substituted heterocyclic compounds for treating multidrug resistance |
| 04/25/2002 | WO2002032868A2 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 04/25/2002 | WO2002032564A1 Process for producing liposome and apparatus therefor |
| 04/25/2002 | WO2002032462A1 Method for making very fine particles consisting of a principle inserted in a host molecule |
| 04/25/2002 | WO2002032460A1 Use of biologically degradable substituted hydrocarbons, the esters, ethers and /or amides thereof for prophylaxis of allergic inhalation reactions and/or for treatment of the nasal mucosa |
| 04/25/2002 | WO2002032454A1 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
| 04/25/2002 | WO2002032444A1 Novel medicinal herbal composition for treating liver diseases and hiv |
| 04/25/2002 | WO2002032437A1 Preparation and xenotransplantation or porcine islets |
| 04/25/2002 | WO2002032433A1 Drug delivery system |
| 04/25/2002 | WO2002032431A1 Compositions for external preparations |
| 04/25/2002 | WO2002032428A1 Oral formulation comprising an inhibitor compound of the ileal bile transport and an hmg co-a reductase inhibitor |
| 04/25/2002 | WO2002032427A1 Stable oral formulation containing benzimidazole derivative |
| 04/25/2002 | WO2002032425A2 Stable oral formulation containing benzimidazole derivative |
| 04/25/2002 | WO2002032424A1 Stable compositions of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers |
| 04/25/2002 | WO2002032423A1 Pharmaceutical compositions containing oxapenem-3-carboxylic acids |
| 04/25/2002 | WO2002032418A1 Therapeutic use of aerosolized s-nitrosoglutathione in cystic fibrosis |
| 04/25/2002 | WO2002032413A2 A method to incorporate n-(4-hydroxyphenyl) retinamide in liposomes |
| 04/25/2002 | WO2002032410A2 Pharmaceutical composition comprising resveratrol for treating inflammatory respiratory disorders |
| 04/25/2002 | WO2002032407A2 Use of hyaluronic acid derivatives for the prevention of inflammatory arthritis |
| 04/25/2002 | WO2002032406A2 Methods and products related to pulmonary delivery of polysaccharides |
| 04/25/2002 | WO2002032405A1 Process for producing gel sheet for application to living body, gel sheet for application to living body obtained by the production process, and method of skin care with the same |
| 04/25/2002 | WO2002032404A2 Nanoparticles |
| 04/25/2002 | WO2002032403A1 Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same |
| 04/25/2002 | WO2002032402A1 Composition and method for stable injectable liquids |
| 04/25/2002 | WO2002032401A1 Amifostine powder injection and its method of process |
| 04/25/2002 | WO2002032400A1 Liposomal formulation of mitoxantrone |
| 04/25/2002 | WO2002032399A1 Taxol liposome composition for treatment of cancer and preparation thereof |
| 04/25/2002 | WO2002032398A2 Lipid-protein-sugar particles for drug delivery |
| 04/25/2002 | WO2002032397A2 Electroprocessing in drug delivery and cell encapsulation |
| 04/25/2002 | WO2002032396A2 Lipid-protein-sugar particles for delivery of nucleic acids |
| 04/25/2002 | WO2002032395A2 Sustained release delivery system and uses thereof |
| 04/25/2002 | WO2002032394A1 Delivery system and method of treating or preventing otitis media |
| 04/25/2002 | WO2002032234A1 Anti-stress composition designed to be mainly incorporated in nutritional carriers |
| 04/25/2002 | WO2002002128A3 Oral compositions comprising antimicrobial agents |
| 04/25/2002 | WO2001093847A3 Compositions, kits, and methods for promoting defined health benefits |
| 04/25/2002 | WO2001093833A3 Kits and methods for optimizing the efficacy of chondroprotective compositions |
| 04/25/2002 | WO2001093832A3 Aqueous chondroprotective compositions having defined dosage requirements for efficacious delivery |
| 04/25/2002 | WO2001093831A3 Low carbohydrate compositions, kits thereof, and methods of use |
| 04/25/2002 | WO2001091728A3 Nanoemulsion formulations |
| 04/25/2002 | WO2001089496A3 Compositions and methods for treating otic, ophthalmic and nasal infections comprising quinolone antibiotics |
| 04/25/2002 | WO2001085131A3 Lipid carrier compositions for improved drug retention |
| 04/25/2002 | WO2001082874A3 A medicinal aerosol formulation |
| 04/25/2002 | WO2001080897A3 Compositions and methods for in vivo delivery of polynucleotide-based therapeutics |
| 04/25/2002 | WO2001052651A3 Particulate blends and compacted products formed therefrom, and the preparation thereof |
| 04/25/2002 | WO2001047913A3 Substituted n-benzyl-indol-3-yl glyoxylic acid derivatives having an anti-tumoral effect |
| 04/25/2002 | WO2001041810A3 Nucleic acid delivery system |
| 04/25/2002 | WO2001028521A3 Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate |
| 04/25/2002 | WO2001010431A3 Headache and colic relief composition with asafetida and method of use thereof |
| 04/25/2002 | US20020049480 Microprocessor controlled ambulatory medical apparatus with hand held communication device |
| 04/25/2002 | US20020049426 Implantable containment apparatus for a therapeutical device |
| 04/25/2002 | US20020049324 Topoisomerase inhibitors |
| 04/25/2002 | US20020049252 Methods, compositions and modes of delivery for the treatment of emphysema using 13-cis-retinoic acid |
| 04/25/2002 | US20020049247 Administering lyposomes of photosensitive receptors or ligands targeted to specific tissues, exposure to light causing destruction of bound tissues; treatment of eye neovascular disease due to macular degeneration, diabetes... |
| 04/25/2002 | US20020049233 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 04/25/2002 | US20020049231 S(-)-3-aminothalidomide; treating wide variety of diseases including diabetic retinopathy |
| 04/25/2002 | US20020049200 Use of a methylol-containing compound to treat tumors |
| 04/25/2002 | US20020049188 Relieving pain associated with anal fissures. |
| 04/25/2002 | US20020049158 Increasing bioavailability of a drug which is not readily absorbed in the digestive tract |
| 04/25/2002 | US20020049156 Polyhudroxy glycopeptide derivatives |
| 04/25/2002 | US20020048822 Marking of products with electroactive compounds |
| 04/25/2002 | US20020048606 Method of preparing microparticles of one or more phytosterols, phytostanols or mixtures of both |
| 04/25/2002 | US20020048605 Fluidity improver and/or anti-agglomeration agent, and a hydrophobic, moisture-proof layer is arranged on the surface of the particles; use in animal feeds, cosmetics and drugs |
| 04/25/2002 | US20020048604 Synthetic membranes and micelle-like structures comprising lipo-gylcoprotein membranes |
| 04/25/2002 | US20020048602 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
| 04/25/2002 | US20020048601 Suppository and composition comprising at least one polyethylene glycol |
| 04/25/2002 | US20020048600 Residual drug content in the device is minimized by the utilization of a flow-promoting layer between a semi-permeable wall; delivery devices having high drug loading |
| 04/25/2002 | US20020048598 Branched polymeric structure which provides a structural support for a mono-layer, bi-layer or multi-layered lipid coating. |
| 04/25/2002 | US20020048597 Reducing the feel of tackiness; increasing stability of oil in water emulsions |
| 04/25/2002 | US20020048596 Preparation for the transport of an active substance across barriers |
| 04/25/2002 | US20020048587 Containing an antigen or at least one in vivo generator of a compound comprising an amino acid sequence. |
| 04/25/2002 | US20020048576 Enzyme that cleaves a linkage that effects release of a cell-surface protein or carbohydrate and a physiologically acceptable carrier for said enzyme; form suitable for oral administration. |
| 04/25/2002 | US20020048570 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/25/2002 | US20020048569 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |
| 04/25/2002 | US20020048568 Plant extract veterinary feed additive; food additive for enhancing weight gain in a recipient; Escherichia coli strain BU-230-98 ATCC Deposit No. 20226 (DSM 12799). |
| 04/25/2002 | US20020048567 Bacterial strain, processed plant extracts, compositions containing same, processes for their preparation and their therapeutic and industrial applications |